http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#Head
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#assertion
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#provenance
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#pubinfo
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#assertion
http://purl.obolibrary.org/obo/DOID_8691
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_8691
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00888
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
http://www.w3.org/2000/01/rdf-schema#label
valchlor is an alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides type cutaneous t cell lymphoma in patients who have received prior skin directed therapy valchlor is an alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides type cutaneous t cell lymphoma in patients who have received prior skin directed therapy 1
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00888
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#provenance
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#pubinfo
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#sig
http://purl.org/nanopub/x/hasSignature
LPv5mgNXUyTQvrQg2DvI3pNPYVwDuXLGqAtrD/Itrm0KJg/9xY8G9+JPcntvL0U0jF+YeCPlXVqEC4y+4YQHPYPaFeLZ9CUTdZ0c1ErATscyorLPqXW2trovTJSHtgLzLiVYZR8w+fXX8m//Mzl45z/l6fQHIfYsjbCrrqB3kS8=
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://purl.org/dc/terms/created
2021-07-03T12:06:00.867+02:00
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA5cu-vLFNpyAABr82MAr7aGS53PObv3RYnmuHAiC9Rig
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs